Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03212742
Title Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients (OLA-TMZ-RTE-01)
Acronym OLA-TMZ-RTE-01
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Amiens France Details
Institut de Cancérologie de l'Ouest Angers France Details
CHU Bordeaux France Details
Centre François Baclesse Caen 14076 France Details
Centre Guillaume le Conquérant Le Havre France Details
CH du Havre Le Havre France Details
GHBS Lorient France Details
Centre léon Bérard Lyon France Details
Hôpitaux universitaires La Pitié Salpétrière - Charles Foix Paris France Details
Institut Curie Paris France Details
Centre Hospitalier Lyon Sud Pierre-Bénite France Details
Centre Eugène Marquis Rennes France Details
Centre Henri Becquerel Rouen France Details
Institut de Cancérologie de l'Ouest Saint-Herblain France Details
Institut Claudius Regaud Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field